Ad scientiam
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Ad scientiam sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Ad scientiam: 5 sponsored US clinical trials, 2 recruiting.
Ad scientiam sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Multiple Sclerosis, with 2 trials.
Upper-quartile sponsor footprint
Ad scientiam sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
NCT05564936
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NCT05566769
MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience
NCT06922942
MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect
NCT05816122
Descriptive Analysis of Real-world Data Collected with ME&MGopen
NCT05566964
Therapeutic Areas
What is open in the Ad scientiam pipeline
2 recruiting of 5 indexed (40% open); 1 completed (20%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Multiple Sclerosis (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ad scientiam: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Ad scientiam sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
- C4 Therapeutics · 40% recruiting · 5 trials
Related
What to do with this Ad scientiam page
5 registered trials is a research-attention snapshot, not an endorsement of Ad scientiam or any single study.
- 2 of Ad scientiam's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition Ad scientiam studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Ad scientiam pipeline card: 5 registered trials from official public datasets.Report a data error.